• 1. Department of Cardiothoracic Surgery, Shanxian Hygeia Hospital, Shanxian, 274300, Shandong, P.R.China;
  • 2. Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
CHEN Longqi, Email: drchenlq@gmail.com
Export PDF Favorites Scan Get Citation

Objective  To analyze the clinical characteristics of patients treated with esophagectomy following endoscopic submucosal dissection (ESD) for early stage esophageal cancer or precancerosis and the reasons for esophagectomy. Methods  We retrospectively analyzed the clinical data of 57 patients who were treated with esophagectomy following ESD in West China Hospital and Shanxian Hygeia Hospital from January 2012 through October 2016. There were 42 males and 15 females at age of 65.4 (52–77) years. There were 15 patients of upper thoracic lesions, the middle thoracic lesions in 34 patients, and the lower thoracic lesions in 8 patients. Results  The reasons for esophagectomy included 3 patients with residual tumor, 8 patients with local recurrence, 37 patients with esophageal stricture, and 9 patients with dysphagia, although the diameter was larger than 1.0 cm. The pathology after esophagectomy revealed that tumor was found in 16 patients, including 3 patients with residual tumor and 8 with recurrent tumor confirmed before esophagectomy, and 5 patients with new-found recurrent tumor. Conclusion  In the treatment of early stage esophageal cancer or precancerosis, the major reasons for esophagectomy following ESD include esophageal stricture, abnormal esophageal dynamics, local residual or recurrence.

Citation: SI Jicheng, HUANG Ben, LIU Haitao, YUANG Yong, CHEN Longqi. Clinical characteristics of 57 patients with early stage esophageal cancer or precancerosis treated with esophagectomy following endoscopic submucosal dissection. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2017, 24(10): 764-767. doi: 10.7507/1007-4848.201612024 Copy

  • Previous Article

    Accuracy and influence factors of preoperative clinical staging for T2 esophageal cancer by endoscopic ultrasound
  • Next Article

    Survival analysis of stage ⅠA non-small cell lung cancer patients with lobectomy and sublobar resection